Company Overview
- Headquarters
- 1350 Avenue of the Americas, 23rd Floor, New York NY
- Website
- promontorytx.com
- Employees
- 24
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Promontory Therapeutics
Promontory Therapeutics is a private, clinical stage biopharmaceutical company based in New York, New York. Founded in 2010, the company employs 24 people. Promontory Therapeutics focuses on the development of phosphaplatins, a novel class of agents designed for the treatment of both solid tumors and hematological cancers. These agents combine an immunological form of apoptosis with a favorable safety profile. The company's lead agent has received approval for two Investigational New Drug (IND) applications with the US Food and Drug Administration (FDA). Promontory Therapeutics also has a collaboration and option agreement with SciClone Pharmaceuticals for rights to phosphaplatins in Greater China. For more information, visit www.phosplatin.com.
Company Leadership
Promontory Therapeutics Industry Tags
Companies Similar to Promontory Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Promontory Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |